1. Home
  2. MEDP vs ALGN Comparison

MEDP vs ALGN Comparison

Compare MEDP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEDP
  • ALGN
  • Stock Information
  • Founded
  • MEDP 1992
  • ALGN 1997
  • Country
  • MEDP United States
  • ALGN United States
  • Employees
  • MEDP N/A
  • ALGN N/A
  • Industry
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • ALGN Industrial Specialties
  • Sector
  • MEDP Health Care
  • ALGN Health Care
  • Exchange
  • MEDP Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • MEDP 10.5B
  • ALGN 12.4B
  • IPO Year
  • MEDP 2016
  • ALGN N/A
  • Fundamental
  • Price
  • MEDP $311.23
  • ALGN $163.98
  • Analyst Decision
  • MEDP Buy
  • ALGN Buy
  • Analyst Count
  • MEDP 10
  • ALGN 12
  • Target Price
  • MEDP $373.22
  • ALGN $262.64
  • AVG Volume (30 Days)
  • MEDP 404.9K
  • ALGN 1.2M
  • Earning Date
  • MEDP 04-21-2025
  • ALGN 04-30-2025
  • Dividend Yield
  • MEDP N/A
  • ALGN N/A
  • EPS Growth
  • MEDP 42.23
  • ALGN N/A
  • EPS
  • MEDP 12.63
  • ALGN 5.62
  • Revenue
  • MEDP $2,109,054,000.00
  • ALGN $3,999,012,000.00
  • Revenue This Year
  • MEDP $4.45
  • ALGN $4.45
  • Revenue Next Year
  • MEDP $9.67
  • ALGN $6.73
  • P/E Ratio
  • MEDP $24.42
  • ALGN $28.13
  • Revenue Growth
  • MEDP 11.84
  • ALGN 3.54
  • 52 Week Low
  • MEDP $289.01
  • ALGN $153.77
  • 52 Week High
  • MEDP $459.77
  • ALGN $331.64
  • Technical
  • Relative Strength Index (RSI)
  • MEDP 42.63
  • ALGN 39.54
  • Support Level
  • MEDP $289.01
  • ALGN $153.77
  • Resistance Level
  • MEDP $331.24
  • ALGN $172.83
  • Average True Range (ATR)
  • MEDP 9.98
  • ALGN 5.63
  • MACD
  • MEDP -1.51
  • ALGN 0.91
  • Stochastic Oscillator
  • MEDP 52.62
  • ALGN 53.57

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: